Search Results - "Sebök, Ágnes"
-
1
Different Roles for RhoA During Neurite Initiation, Elongation, and Regeneration in PC12 Cells
Published in Journal of neurochemistry (01-09-1999)“…: The goal of the present study was to characterize the effects of RhoA at different stages of nerve growth factor (NGF)‐induced neuronal differentiation in…”
Get full text
Journal Article -
2
Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho
Published in Journal of neurochemistry (01-02-1996)“…The endogenous phospholipid mediator lysophosphatidic acid (LPA) caused growth cone collapse, neurite retraction, and cell flattening in differentiated PC12…”
Get more information
Journal Article -
3
Weight reduction added to CPAP decreases blood pressure and triglyceride level in OSA: Systematic review and meta‐analysis
Published in Clinical and translational science (01-05-2022)“…Obstructive sleep apnea (OSA) is associated with treatment‐resistant hypertension and high cardiovascular risk. Continuous positive airway pressure (CPAP)…”
Get full text
Journal Article -
4
Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling
Published in Journal of neurochemistry (01-02-1996)“…Effects of the cyclic AMP second messenger system were studied on the retraction of neurites elicited by the phospholipid mediator lysophosphatidic acid (LPA)…”
Get more information
Journal Article -
5
Cyclic phosphatidic acid elicits neurotrophin‐like actions in embryonic hippocampal neurons
Published in Journal of neurochemistry (01-12-2003)“…Cyclic phosphatidic acid (cPA; 1‐acyl‐sn‐glycerol‐2,3‐cyclic phosphate) is an analog of the growth factor‐like phospholipid mediator lysophosphatidic acid…”
Get full text
Journal Article -
6
Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease
Published in Life (Basel, Switzerland) (31-05-2021)“…Pompe disease is caused by the accumulation of glycogen in the lysosomes due to a deficiency of the lysosomal acid-α-glucosidase (GAA) enzyme. Depending on…”
Get full text
Journal Article -
7
Inactivation of Rho Signaling Pathway Promotes CNS Axon Regeneration
Published in The Journal of neuroscience (01-09-1999)“…Regeneration in the CNS is blocked by many different growth inhibitory proteins. To foster regeneration, we have investigated a strategy to block the neuronal…”
Get full text
Journal Article -
8
Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases
Published in Muscle & nerve (01-04-2017)“…ABSTRACT Introduction: Human fibroblast growth factor 21 (FGF21) is a regulator of lipid and glucose metabolism. It is expressed in skeletal muscle and may be…”
Get full text
Journal Article -
9
Rhabdomyolysis - may it be a metabolic myopathy? Case report and diagnostic algorithm
Published in Orvosi hetilap (01-11-2017)“…We report the case of a 46-year-old female patient with recurrent rhabdomyolysis. In the background of her metabolic myopathy an inherited metabolic disorder…”
Get more information
Journal Article -
10
A késői kezdetű Pompe-kórban szenvedők enzimpótló kezelésének hosszú távú követése
Published in Ideggyógyászati szemle (2020)Get full text
Journal Article -
11
The long-term follow-up of enzyme replacement treatment in late onset Pompe disease
Published in Ideggyógyászati szemle (30-05-2020)Get full text
Journal Article -
12
A quick balance assessment tool for all clinical settings: validity and reliability of the Hungarian version of the activities-specific balance confidence scale
Published in Physiotherapy theory and practice (03-09-2024)“…The Activities-specific Balance Confidence Scale was developed for testing the balance confidence of elderly individuals, and it has been used extensively for…”
Get full text
Journal Article -
13
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Published in Journal of neurology (01-05-2024)“…The phase III double-blind PROPEL study compared the novel two-component therapy cipaglucosidase alfa + miglustat (cipa + mig) with alglucosidase alfa +…”
Get full text
Journal Article -
14
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
Published in Journal of patient-reported outcomes (13-11-2024)“…Background Late-onset Pompe disease (LOPD), a rare autosomal recessive multisystemic disorder, substantially impacts patients’ day-to-day activities, outcomes,…”
Get full text
Journal Article -
15
The Role of RhoA Protein in Neuronal Differentiation
Published 01-01-2000“…The first Rho protein was found by (and named after) its homology to Ras proteins; (1), members of the Rho family, however, have a much weaker transforming…”
Get full text
Dissertation